Testosterone Replacement Therapy
Areas we serve in ME and NH
GLP-1 Weight Loss
Hormone Replacement Therapy
Functional Medicine
Services & Treatments
Conditions We Treat
INSIGHTS
Functional medicine insights, treatment guides, and health education from the Med Matrix team.
We rebuilt medmatrixusa.com from scratch. New service pages, real patient stories, provider bios, podcast episodes, and a faster, easier experience on every device.
Semaglutide weighs 4,113 daltons. Nicotine, the classic patch drug, weighs 162. That size gap is the entire reason a GLP-1 patch cannot work, plus what does.
Thyroid belly is not a medical diagnosis, and the experience behind it is still real. What a slow thyroid does to your midsection, and why TSH alone misses it.
Bone density can drop during GLP-1 weight loss. So can muscle. Neither is a reason to stop, and neither is inevitable, but almost nobody is measuring them.
A daily multivitamin is not a scam, and it is not the insurance policy the label implies. What it does depends on what is actually low in you, and most people taking one have never found out.
For 20 years a warning label kept many women away from hormone therapy. The FDA is removing it and updated the first labels in 2026. What changed, what stayed the same, and why the decision is still individual.
Reflux gets treated by turning the acid down, which quiets the signal without answering what set it off. Here are the root causes conventional care skips, including low stomach acid.
About one in three women 35 and older cannot say whether they are in perimenopause. Here is why the confusion is so common, and how to actually find out.
FDA scientists recommended against making seven peptides easier to compound, and an advisory committee votes July 23-24, 2026. What the review covers, why it is not a ban, and what it means if peptides are part of your plan.
You cleaned up your diet but the scale barely moved. A 2026 WHO study of 15,200 people found ultra-processed food leaves a measurable fingerprint in your blood. What those markers mean, and why the scale is the wrong scoreboard for how food is treating you.
The FDA's proposal to end large-scale compounding of semaglutide has a new comment deadline: July 30, 2026. The direction has not changed. What the docket means if you're on a compounded GLP-1, and how to plan a transition before the rule is final.
A 13,000-patient cohort presented at Heart Rhythm 2026 found GLP-1 medications tied to lower atrial fibrillation risk, even in patients who gained weight. What the finding means, what it does not, and who should keep an eye on heart rhythm during treatment.
For decades, chronic fatigue could only be diagnosed by ruling everything else out. New research on a blood test with 96 percent accuracy is changing that, and it validates every patient who was told their labs look normal.
